New drug takes first step in fight against high blood pressure
NCT ID NCT06501586
Summary
This early-stage study tested a new experimental drug called SGB-3908 for high blood pressure. Researchers gave single doses to 40 healthy volunteers and people with mild hypertension to check if it's safe and how the body processes it. The main goal was to see what side effects might occur and measure drug levels in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION,ESSENTIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100083, China
Conditions
Explore the condition pages connected to this study.